BFC Planning’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
BFC Planning's RDY Position: Q3 2026 in Review
BFC Planning held its Dr. Reddy's Laboratories (RDY) position steady in Q3 2026 at 5,500 shares worth $69.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1405.
BFC Planning first reported a position in RDY in Q3 2024 and has held it in 9 quarters since. The position peaked at $79.7K in Q2 2026. 186 funds tracked by Wall St. Rank hold RDY as of Q3 2026.
- BFC Planning held 5,500 shares of Dr. Reddy's Laboratories worth $69.4K as of Q3 2026.
- BFC Planning left its Dr. Reddy's Laboratories share count unchanged in Q3 2026.
- Dr. Reddy's Laboratories made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1405 holding.
- BFC Planning first reported a position in Dr. Reddy's Laboratories in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Dr. Reddy's Laboratories position peaked at $79.7K in Q2 2026.
- 186 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.